Starus Pharmaceuticals Private Limited, a active private limited company, was established on 22 December 2016 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304TG2016PTC113632. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Ramesh Kumar Modukuri (Director), Udaya Kiran Perla (Managing Director). Past directors included Sai Prasanthi Kodali, Santhi Yamaka, Udaya Kiran Perla. It holds ₹3.23 Cr open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Flat No.101, Plot No.239,1St Floor, Sri Rama Nilayam, Phase 1, Kamalapuri Co, Lony, Hyderabad, Telangana, 500045.
U24304TG2016PTC113632
113632
22 December 2016
₹1.00 Cr
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Starus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Kumar Modukuri | Director | 23 Jul 2019 | Current |
| Udaya Kiran Perla | Managing Director | 22 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jul 2018 | Past |
| Pramod Abcsdd | Director | 14 Aug 2022 | Past |
| Pramod Abcsdd | Director | 13 Aug 2019 | Past |
| Pramod Abcsdd | Director | 14 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Starus Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.65% decrease. The company also saw a substantial improvement in profitability, with a 82.16% increase in profit. The company's net worth observed a substantial decline by a decrease of 57.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Starus Pharmaceuticals had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹32,291,900.00
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2024 | Others | ₹1.38 Cr | Open |
| 23 Jul 2021 | Others | ₹9.96 M | Open |
| 19 Jun 2020 | Others | ₹2.23 M | Open |
| 15 Apr 2019 | Yes Bank Limited | ₹6.30 M | Open |
| 10 Oct 2019 | Others | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Starus Pharmaceuticals has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Starus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Starus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 1.38 Cr with Charge ID 100872731 was registered on 20 Feb 2024. was completed.
Progress on A charge with Others of Rs. 1.00 Cr registered on 23 Jul 2021 with Charge ID 100470670 was modified on 30 Dec 2023. was documented.
The activity A charge registered on 10 Oct 2019 via Charge ID 100293385 with Others was fully satisfied on 29 Aug 2023. was completed.
Progress on Starus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Starus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100470670 was registered on 23 Jul 2021. was recorded as a recent event.
The CIN of Starus Pharmaceuticals Private Limited is U24304TG2016PTC113632.
Starus Pharmaceuticals Private Limited is headquartered at Flat No.101, Plot No.239,1St Floor, Sri Rama Nilayam, Phase 1, Kamalapuri Co, Lony, Hyderabad, Telangana, 500045.
Starus Pharmaceuticals Private Limited was incorporated on 22 December 2016.
The current directors of Starus Pharmaceuticals Private Limited are
The primary industry of Starus Pharmaceuticals Private Limited is Trade.
Starus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Starus Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 M.
The compliance status of Starus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX